Status:
COMPLETED
Neonatal Suspected Sepsis Treated With Cefazolin or Vancomycin
Lead Sponsor:
Hospital Italiano de Buenos Aires
Conditions:
Nosocomial Neonatal Sepsis
Eligibility:
All Genders
4-4 years
Phase:
PHASE3
Brief Summary
The objective is to evaluate the effectiveness of empiric treatment with cefazolin versus to vancomycin in newborn infants with presumptive clinical signs of hospital acquired bacterial sepsis probabl...
Eligibility Criteria
Inclusion
- Newborn infants older than three days of life with suspected bacterial sepsis and according to attending physicians, with an indication for initial treatment with vancomycin and at least one blood culture taken prior to receiving the antimicrobial treatment.
Exclusion
- previous treatment with vancomycin during the week before,
- infants referred from other hospitals and, upon admission, were being treated with antibiotics.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01867138
Start Date
March 1 2007
End Date
January 1 2011
Last Update
June 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano de Buenos Aires
Buenos Aires, Capital, Argentina, 1181